Parsvnath Developers Ltd
₹3.03
-0.06 (1.94%)
Fri, 06 Nov 2026, 09:22 pm
Parsvnath Developers News
Parsvnath Developers CS Resigns Citing Financial Instability
Atul Kumar Gupta resigns as Company Secretary and Compliance Officer of Parsvnath Developers Ltd effective July 28, 2026, citing financial instability and career interests.
29 Jul 2026
companies
Parsvnath Developers directors resign
Three independent directors resigned from Parsvnath Developers Ltd on July 14, 2026, citing personal and health reasons. The resignations were disclosed to exchanges on July 16, 2026.
17 Jul 2026
companies
Supreme Court freezes Parsvnath Developers accounts
Supreme Court freezes bank accounts of Parsvnath Developers and its subsidiary, issuing bailable warrants against directors for non-compliance with HRERA orders.
14 Jul 2026
companies
Parsvnath promoters hold 49.86% stake
Parsvnath Developers Ltd declared no encumbrance of shares by promoters for FY 2025-2026. Promoters hold 49.86% stake.
08 Jul 2026
companies
Parsvnath confirms no encumbrance of promoter shares
Parsvnath Developers filed a declaration confirming no new encumbrance of promoter shares for FY 2025-2026. Promoters and PACs hold 49.86% stake.
06 Jun 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo